27
Apr
Amvac Corporation Charts Risky Business Model
(Beyond Pesticides, April 27, 2007) Health risk, environmental risk and investment risk all have one thing in common — they are all part of Amvac Chemical Corporation’s business practices. According to a Los Angeles Times investigation earlier this month, this socially irresponsible business model has led Amvac to double-digit revenue growth and a toxic legacy. The Amvac homepage reads, “The Company’s chief strategy is to acquire niche product lines from multi-billion dollar companies that divest mature products to focus on newly discovered molecules. The Company’s products include insecticides, fungicides, herbicides, soil fumigants, defoliants, molluscides and growth regulators.” In actuality, Amvac buys the rights to older, high risk pesticides from larger companies. Many of these pesticides, which are some of the most toxic on the market, are likely to be banned or restricted due to safety concerns. Amvac hires scientists and lawyers to keep these dangerous chemicals on the market as long as possible. The company also often skirts regulatory issues by exporting products to countries with weaker regulatory systems. “There’s something here rather unique, which is a company that basically goes intentionally after chemicals that are in trouble because of health and safety concerns,” said Steve Schatzow, a former director […]
